disease drugs – Talk Bio

Actionable Insights Powered by AI

Novo Nordisk Invests $1.2 Billion in New Danish Production Facility for Rare Disease Therapies

Novo Nordisk, rare disease drugs, Denmark, production facility, investment, hemophilia, pharmaceutical manufacturing